A comparison of glycemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during Ramadan fasting
- 28 February 2007
- journal article
- research article
- Published by Elsevier BV in Diabetes Research and Clinical Practice
- Vol. 75 (2), 141-147
- https://doi.org/10.1016/j.diabres.2006.05.012
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Recommendations for Management of Diabetes During RamadanDiabetes Care, 2005
- The Efficacy and Safety of Glimepiride in the Management of Type 2 Diabetes in Muslim Patients During RamadanDiabetes Care, 2005
- A Population-Based Study of Diabetes and Its Characteristics During the Fasting Month of Ramadan in 13 CountriesDiabetes Care, 2004
- The Effects of Diet, Sulfonylurea, and Repaglinide Therapy on Clinical and Metabolic Parameters in Type 2 Diabetic Patients During RamadanEndocrine Research, 2004
- Insulin GlargineHeart Disease, 2003
- Insulin lispro (Lys(B28), Pro(B29)) in the treatment of diabetes during the fasting month of RamadanDiabetic Medicine, 1999
- Fasting during Ramadan Induces a Marked Increase in High-Density Lipoprotein Cholesterol and Decrease in Low-Density Lipoprotein CholesterolAnnals of Nutrition and Metabolism, 1997
- Tests of Glycemia in DiabetesDiabetes Care, 1995
- Muslims with non-insulin dependent diabetes fasting during Ramadan: treatment with glibenclamide.BMJ, 1993
- Ramadan Fasting In Diabetic Children in RiyadhDiabetic Medicine, 1992